ID TBB8_HUMAN Reviewed; 444 AA. AC Q3ZCM7; Q5SQX9; Q8WZ78; DT 26-FEB-2008, integrated into UniProtKB/Swiss-Prot. DT 26-FEB-2008, sequence version 2. DT 04-NOV-2026, entry version 166. DE RecName: Full=Tubulin beta-8 chain {ECO:0000305}; DE AltName: Full=Tubulin beta 8 class VIII {ECO:0000312|HGNC:HGNC:20773}; GN Name=TUBB8 {ECO:0000312|HGNC:HGNC:20773}; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=11731935; DOI=10.1086/338307; RA van Geel M., Eichler E.E., Beck A.F., Shan Z., Haaf T., RA van der Maarel S.M., Frants R.R., de Jong P.J.; RT "A cascade of complex subtelomeric duplications during the evolution of the RT hominoid and Old World monkey genomes."; RL Am. J. Hum. Genet. 70:269-278(2002). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Fetal brain; RA Li W.B., Gruber C., Jessee J., Polayes D.; RT "Full-length cDNA libraries and normalization."; RL Submitted (JUL-2004) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15164054; DOI=10.1038/nature02462; RA Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L., RA Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K., RA Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L., RA Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P., RA Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J., RA Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y., RA Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P., RA Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N., RA Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A., RA Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C., RA Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D., RA Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C., RA Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K., RA Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A., RA Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S., RA McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S., RA Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., RA Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., RA Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M., RA Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A., RA Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P., RA Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y., RA Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D., RA Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.; RT "The DNA sequence and comparative analysis of human chromosome 10."; RL Nature 429:375-381(2004). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases. RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 4-444. RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [6] RP PHOSPHORYLATION AT SER-172. RX PubMed=16371510; DOI=10.1091/mbc.e05-07-0621; RA Fourest-Lieuvin A., Peris L., Gache V., Garcia-Saez I., Juillan-Binard C., RA Lantez V., Job D.; RT "Microtubule regulation in mitosis: tubulin phosphorylation by the cyclin- RT dependent kinase Cdk1."; RL Mol. Biol. Cell 17:1041-1050(2006). RN [7] RP GLYCYLATION. RX PubMed=19524510; DOI=10.1016/j.cell.2009.05.020; RA Rogowski K., Juge F., van Dijk J., Wloga D., Strub J.-M., Levilliers N., RA Thomas D., Bre M.-H., Van Dorsselaer A., Gaertig J., Janke C.; RT "Evolutionary divergence of enzymatic mechanisms for posttranslational RT polyglycylation."; RL Cell 137:1076-1087(2009). RN [8] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21269460; DOI=10.1186/1752-0509-5-17; RA Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., RA Bennett K.L., Superti-Furga G., Colinge J.; RT "Initial characterization of the human central proteome."; RL BMC Syst. Biol. 5:17-17(2011). RN [9] RP GLUTAMYLATION. RX PubMed=26875866; DOI=10.1016/j.cell.2016.01.019; RA Valenstein M.L., Roll-Mecak A.; RT "Graded control of microtubule severing by tubulin glutamylation."; RL Cell 164:911-921(2016). RN [10] RP INVOLVEMENT IN OZEMA2, VARIANTS OZEMA2 27-GLU--ALA-33 DEL; LEU-176; RP VAL-210; MET-238; MET-255; TRP-262; PRO-285 AND SER-348, AND RP CHARACTERIZATION OF VARIANTS OZEMA2 27-GLU--ALA-33 DEL; LEU-176; VAL-210; RP MET-238; MET-255; TRP-262; PRO-285 AND SER-348. RX PubMed=27273344; DOI=10.1136/jmedgenet-2016-103891; RA Feng R., Yan Z., Li B., Yu M., Sang Q., Tian G., Xu Y., Chen B., Qu R., RA Sun Z., Sun X., Jin L., He L., Kuang Y., Cowan N.J., Wang L.; RT "Mutations in TUBB8 cause a multiplicity of phenotypes in human oocytes and RT early embryos."; RL J. Med. Genet. 53:662-671(2016). RN [11] RP FUNCTION, TISSUE SPECIFICITY, SUBCELLULAR LOCATION, INVOLVEMENT IN OZEMA2, RP VARIANTS OZEMA2 LYS-2; LEU-176; ALA-229; GLN-262; ILE-300; THR-363 AND RP ASN-417, AND CHARACTERIZATION OF VARIANTS OZEMA2 LYS-2; LEU-176; ALA-229; RP GLN-262; ILE-300; THR-363 AND ASN-417. RX PubMed=26789871; DOI=10.1056/nejmoa1510791; RA Feng R., Sang Q., Kuang Y., Sun X., Yan Z., Zhang S., Shi J., Tian G., RA Luchniak A., Fukuda Y., Li B., Yu M., Chen J., Xu Y., Guo L., Qu R., RA Wang X., Sun Z., Liu M., Shi H., Wang H., Feng Y., Shao R., Chai R., Li Q., RA Xing Q., Zhang R., Nogales E., Jin L., He L., Gupta M.L. Jr., Cowan N.J., RA Wang L.; RT "Mutations in TUBB8 and human oocyte meiotic arrest."; RL N. Engl. J. Med. 374:223-232(2016). RN [12] RP VARIANT OZEMA2 VAL-54. RX PubMed=32316999; DOI=10.1186/s13048-020-00637-4; RA Xing Q., Wang R., Chen B., Li L., Pan H., Li T., Ma X., Cao Y., Wang B.; RT "Rare homozygous mutation in TUBB8 associated with oocyte maturation RT defect-2 in a consanguineous mating family."; RL J. Ovarian Res. 13:42-42(2020). RN [13] RP VARIANTS OZEMA2 VAL-54 AND HIS-320, CHARACTERIZATION OF VARIANTS OZEMA2 RP VAL-54 AND HIS-320, AND FUNCTION. RX PubMed=34509376; DOI=10.1016/j.rbmo.2021.07.020; RA Cao T., Guo J., Xu Y., Lin X., Deng W., Cheng L., Zhao H., Jiang S., RA Gao M., Huang J., Xu Y.; RT "Two mutations in TUBB8 cause developmental arrest in human oocytes and RT early embryos."; RL Reprod. BioMed. Online 43:891-898(2021). CC -!- FUNCTION: Tubulin is the major constituent of microtubules, a cylinder CC consisting of laterally associated linear protofilaments composed of CC alpha- and beta-tubulin heterodimers. Microtubules grow by the addition CC of GTP-tubulin dimers to the microtubule end, where a stabilizing cap CC forms. Below the cap, tubulin dimers are in GDP-bound state, owing to CC GTPase activity of alpha-tubulin. TUBB8 has a key role in meiotic CC spindle assembly and oocyte maturation (PubMed:26789871, CC PubMed:34509376). {ECO:0000269|PubMed:26789871, CC ECO:0000269|PubMed:34509376}. CC -!- COFACTOR: CC Name=Mg(2+); Xref=ChEBI:CHEBI:18420; CC Evidence={ECO:0000250|UniProtKB:P68363}; CC -!- SUBUNIT: Dimer of alpha and beta chains. A typical microtubule is a CC hollow water-filled tube with an outer diameter of 25 nm and an inner CC diameter of 15 nM. Alpha-beta heterodimers associate head-to-tail to CC form protofilaments running lengthwise along the microtubule wall with CC the beta-tubulin subunit facing the microtubule plus end conferring a CC structural polarity. Microtubules usually have 13 protofilaments but CC different protofilament numbers can be found in some organisms and CC specialized cells. CC -!- INTERACTION: CC Q3ZCM7; O75529: TAF5L; NbExp=3; IntAct=EBI-302558, EBI-1785876; CC -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton CC {ECO:0000269|PubMed:26789871}. Cytoplasm, cytoskeleton, spindle CC {ECO:0000269|PubMed:26789871}. CC -!- TISSUE SPECIFICITY: Expressed at a high level in oocytes, at different CC stages of development. {ECO:0000269|PubMed:26789871}. CC -!- DOMAIN: The MREI motif is common among all beta-tubulin isoforms and CC may be critical for tubulin autoregulation. CC {ECO:0000250|UniProtKB:P07437}. CC -!- PTM: Some glutamate residues at the C-terminus are polyglutamylated, CC resulting in polyglutamate chains on the gamma-carboxyl group CC (PubMed:26875866). Polyglutamylation plays a key role in microtubule CC severing by spastin (SPAST). SPAST preferentially recognizes and acts CC on microtubules decorated with short polyglutamate tails: severing CC activity by SPAST increases as the number of glutamates per tubulin CC rises from one to eight, but decreases beyond this glutamylation CC threshold (PubMed:26875866). Glutamylation is also involved in cilia CC motility (By similarity). {ECO:0000250|UniProtKB:P99024, CC ECO:0000269|PubMed:26875866}. CC -!- PTM: Some glutamate residues at the C-terminus are monoglycylated but CC not polyglycylated due to the absence of functional TTLL10 in human. CC Monoglycylation is mainly limited to tubulin incorporated into cilia CC and flagella axonemes, which is required for their stability and CC maintenance. Flagella glycylation controls sperm motility. Both CC polyglutamylation and monoglycylation can coexist on the same protein CC on adjacent residues, and lowering glycylation levels increases CC polyglutamylation, and reciprocally. {ECO:0000250|UniProtKB:P07437, CC ECO:0000305|PubMed:19524510}. CC -!- PTM: Phosphorylated on Ser-172 by CDK1 during the cell cycle, from CC metaphase to telophase, but not in interphase. This phosphorylation CC inhibits tubulin incorporation into microtubules. CC {ECO:0000269|PubMed:16371510}. CC -!- DISEASE: Oocyte/zygote/embryo maturation arrest 2 (OZEMA2) CC [MIM:616780]: A primary infertility disorder caused by defective oocyte CC maturation. Oocytes are arrested at metaphase I, and have an abnormal CC or no detectable spindle on polarization microscopy. OOMD2 inheritance CC can be autosomal dominant or autosomal recessive. CC {ECO:0000269|PubMed:26789871, ECO:0000269|PubMed:27273344, CC ECO:0000269|PubMed:32316999, ECO:0000269|PubMed:34509376}. Note=The CC disease is caused by variants affecting the gene represented in this CC entry. CC -!- SIMILARITY: Belongs to the tubulin family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF355127; AAL32434.1; -; Genomic_DNA. DR EMBL; CR590375; -; NOT_ANNOTATED_CDS; mRNA. DR EMBL; AL713922; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH471072; EAW86545.1; -; Genomic_DNA. DR EMBL; BC101270; AAI01271.1; -; mRNA. DR EMBL; BC101271; AAI01272.1; -; mRNA. DR CCDS; CCDS7051.1; -. DR RefSeq; NP_817124.1; NM_177987.3. DR AlphaFoldDB; Q3ZCM7; -. DR SMR; Q3ZCM7; -. DR BioGRID; 131462; 599. DR CORUM; Q3ZCM7; -. DR FunCoup; Q3ZCM7; 1424. DR IntAct; Q3ZCM7; 337. DR NDEx; IQUERY-CP-TUBB8; 6 NDEx IQuery Curated Pathways. DR STRING; 9606.ENSP00000456206; -. DR BindingDB; Q3ZCM7; -. DR ChEMBL; CHEMBL4024; -. DR DrugCentral; Q3ZCM7; -. DR GlyGen; Q3ZCM7; 1 site, 1 O-linked glycan (1 site). DR iPTMnet; Q3ZCM7; -. DR MetOSite; Q3ZCM7; -. DR PhosphoSitePlus; Q3ZCM7; -. DR SwissPalm; Q3ZCM7; -. DR BioMuta; TUBB8; -. DR DMDM; 182705285; -. DR jPOST; Q3ZCM7; -. DR MassIVE; Q3ZCM7; -. DR PaxDb; 9606-ENSP00000456206; -. DR PeptideAtlas; Q3ZCM7; -. DR ProteomicsDB; 61904; -. DR Pumba; Q3ZCM7; -. DR Antibodypedia; 59334; 107 antibodies from 22 providers. DR DNASU; 347688; -. DR Ensembl; ENST00000568584.6; ENSP00000456206.2; ENSG00000261456.6. DR GeneID; 347688; -. DR KEGG; hsa:347688; -. DR MANE-Select; ENST00000568584.6; ENSP00000456206.2; NM_177987.3; NP_817124.1. DR UCSC; uc001ifi.3; human. DR AGR; HGNC:20773; -. DR CTD; 347688; -. DR DisGeNET; 347688; -. DR GeneCards; TUBB8; -. DR HGNC; HGNC:20773; TUBB8. DR HPA; ENSG00000261456; Tissue enhanced (ovary, testis). DR MalaCards; TUBB8; -. DR MIM; 616768; gene. DR MIM; 616780; phenotype. DR OpenTargets; ENSG00000261456; -. DR Orphanet; 488191; Female infertility due to oocyte meiotic arrest. DR VEuPathDB; HostDB:ENSG00000261456; -. DR eggNOG; KOG1375; Eukaryota. DR GeneTree; ENSGT00940000161436; -. DR InParanoid; Q3ZCM7; -. DR OMA; CMMSTKE; -. DR OrthoDB; 1662883at2759; -. DR PAN-GO; Q3ZCM7; 6 GO annotations based on evolutionary models. DR PhylomeDB; Q3ZCM7; -. DR PathwayCommons; Q3ZCM7; -. DR Reactome; R-HSA-1445148; Translocation of SLC2A4 (GLUT4) to the plasma membrane. DR Reactome; R-HSA-190840; Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane. DR Reactome; R-HSA-190861; Gap junction assembly. DR Reactome; R-HSA-2132295; MHC class II antigen presentation. DR Reactome; R-HSA-2467813; Separation of Sister Chromatids. DR Reactome; R-HSA-2500257; Resolution of Sister Chromatid Cohesion. DR Reactome; R-HSA-3371497; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand. DR Reactome; R-HSA-380320; Recruitment of NuMA to mitotic centrosomes. DR Reactome; R-HSA-437239; Recycling pathway of L1. DR Reactome; R-HSA-5620920; Cargo trafficking to the periciliary membrane. DR Reactome; R-HSA-5626467; RHO GTPases activate IQGAPs. DR Reactome; R-HSA-5663220; RHO GTPases Activate Formins. DR Reactome; R-HSA-6807878; COPI-mediated anterograde transport. DR Reactome; R-HSA-6811434; COPI-dependent Golgi-to-ER retrograde traffic. DR Reactome; R-HSA-6811436; COPI-independent Golgi-to-ER retrograde traffic. DR Reactome; R-HSA-68877; Mitotic Prometaphase. DR Reactome; R-HSA-8852276; The role of GTSE1 in G2/M progression after G2 checkpoint. DR Reactome; R-HSA-8955332; Carboxyterminal post-translational modifications of tubulin. DR Reactome; R-HSA-9609690; HCMV Early Events. DR Reactome; R-HSA-9609736; Assembly and cell surface presentation of NMDA receptors. DR Reactome; R-HSA-9619483; Activation of AMPK downstream of NMDARs. DR Reactome; R-HSA-9646399; Aggrephagy. DR Reactome; R-HSA-9648025; EML4 and NUDC in mitotic spindle formation. DR Reactome; R-HSA-9668328; Sealing of the nuclear envelope (NE) by ESCRT-III. DR Reactome; R-HSA-983189; Kinesins. DR Reactome; R-HSA-9833482; PKR-mediated signaling. DR Reactome; R-HSA-9979719; Processing of antigen in germinal center B cells. DR SignaLink; Q3ZCM7; -. DR Agora; ENSG00000261456; -. DR BioGRID-ORCS; 347688; 378 hits in 1067 CRISPR screens. DR CD-CODE; 91857CE7; Nucleolus. DR CD-CODE; DEE660B4; Stress granule. DR GenomeRNAi; 347688; -. DR Pharos; Q3ZCM7; Tclin. DR PRO; PR:Q3ZCM7; -. DR Proteomes; UP000005640; Chromosome 10. DR RNAct; Q3ZCM7; protein. DR Bgee; ENSG00000261456; Expressed in primordial germ cell in gonad and 84 other cell types or tissues. DR ExpressionAtlas; Q3ZCM7; baseline and differential. DR GO; GO:0097542; C:ciliary tip; IDA:HPA. DR GO; GO:0005929; C:cilium; IDA:HPA. DR GO; GO:0005737; C:cytoplasm; IBA:GO_Central. DR GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB. DR GO; GO:0045171; C:intercellular bridge; IDA:HPA. DR GO; GO:0072687; C:meiotic spindle; IDA:UniProtKB. DR GO; GO:0005874; C:microtubule; IBA:GO_Central. DR GO; GO:0015630; C:microtubule cytoskeleton; IDA:HPA. DR GO; GO:0072686; C:mitotic spindle; IDA:HPA. DR GO; GO:0097229; C:sperm end piece; IDA:HPA. DR GO; GO:0097228; C:sperm principal piece; IDA:HPA. DR GO; GO:0005525; F:GTP binding; IBA:GO_Central. DR GO; GO:0003924; F:GTPase activity; IEA:InterPro. DR GO; GO:0005200; F:structural constituent of cytoskeleton; IBA:GO_Central. DR GO; GO:0000226; P:microtubule cytoskeleton organization; IBA:GO_Central. DR GO; GO:0000278; P:mitotic cell cycle; IBA:GO_Central. DR GO; GO:0001556; P:oocyte maturation; IMP:UniProtKB. DR GO; GO:0007056; P:spindle assembly involved in female meiosis; IMP:UniProtKB. DR CDD; cd02187; beta_tubulin; 1. DR FunFam; 1.10.287.600:FF:000002; Tubulin beta chain; 1. DR FunFam; 3.30.1330.20:FF:000002; Tubulin beta chain; 1. DR FunFam; 3.40.50.1440:FF:000025; Tubulin beta chain; 1. DR FunFam; 3.40.50.1440:FF:000018; Tubulin beta chain, putative; 1. DR Gene3D; 1.10.287.600; Helix hairpin bin; 1. DR Gene3D; 3.30.1330.20; Tubulin/FtsZ, C-terminal domain; 1. DR Gene3D; 3.40.50.1440; Tubulin/FtsZ, GTPase domain; 1. DR InterPro; IPR013838; Beta-tubulin_BS. DR InterPro; IPR002453; Beta_tubulin. DR InterPro; IPR008280; Tub_FtsZ_C. DR InterPro; IPR000217; Tubulin. DR InterPro; IPR037103; Tubulin/FtsZ-like_C. DR InterPro; IPR018316; Tubulin/FtsZ_2-layer-sand-dom. DR InterPro; IPR036525; Tubulin/FtsZ_GTPase_sf. DR InterPro; IPR023123; Tubulin_C. DR InterPro; IPR017975; Tubulin_CS. DR InterPro; IPR003008; Tubulin_FtsZ_GTPase. DR PANTHER; PTHR11588; TUBULIN; 1. DR Pfam; PF00091; Tubulin; 1. DR Pfam; PF03953; Tubulin_C; 1. DR PRINTS; PR01163; BETATUBULIN. DR PRINTS; PR01161; TUBULIN. DR SMART; SM00864; Tubulin; 1. DR SMART; SM00865; Tubulin_C; 1. DR SUPFAM; SSF55307; Tubulin C-terminal domain-like; 1. DR SUPFAM; SSF52490; Tubulin nucleotide-binding domain-like; 1. DR PROSITE; PS00227; TUBULIN; 1. DR PROSITE; PS00228; TUBULIN_B_AUTOREG; 1. PE 1: Evidence at protein level; KW Cytoplasm; Cytoskeleton; Disease variant; GTP-binding; Isopeptide bond; KW Magnesium; Metal-binding; Microtubule; Nucleotide-binding; Phosphoprotein; KW Proteomics identification; Reference proteome. FT CHAIN 1..444 FT /note="Tubulin beta-8 chain" FT /id="PRO_0000320631" FT REGION 423..444 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOTIF 1..4 FT /note="MREI motif" FT /evidence="ECO:0000250|UniProtKB:P07437" FT COMPBIAS 429..444 FT /note="Acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT BINDING 11 FT /ligand="GTP" FT /ligand_id="ChEBI:CHEBI:37565" FT /evidence="ECO:0000250|UniProtKB:Q13509" FT BINDING 69 FT /ligand="GTP" FT /ligand_id="ChEBI:CHEBI:37565" FT /evidence="ECO:0000250|UniProtKB:P68363" FT BINDING 69 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /evidence="ECO:0000250|UniProtKB:P68363" FT BINDING 138 FT /ligand="GTP" FT /ligand_id="ChEBI:CHEBI:37565" FT /evidence="ECO:0000250|UniProtKB:Q13509" FT BINDING 142 FT /ligand="GTP" FT /ligand_id="ChEBI:CHEBI:37565" FT /evidence="ECO:0000250|UniProtKB:Q13509" FT BINDING 143 FT /ligand="GTP" FT /ligand_id="ChEBI:CHEBI:37565" FT /evidence="ECO:0000250|UniProtKB:Q13509" FT BINDING 144 FT /ligand="GTP" FT /ligand_id="ChEBI:CHEBI:37565" FT /evidence="ECO:0000250|UniProtKB:Q13509" FT BINDING 204 FT /ligand="GTP" FT /ligand_id="ChEBI:CHEBI:37565" FT /evidence="ECO:0000250|UniProtKB:Q13509" FT BINDING 226 FT /ligand="GTP" FT /ligand_id="ChEBI:CHEBI:37565" FT /evidence="ECO:0000250|UniProtKB:Q13509" FT MOD_RES 172 FT /note="Phosphoserine; by CDK1" FT /evidence="ECO:0000269|PubMed:16371510" FT MOD_RES 436 FT /note="5-glutamyl polyglutamate" FT /evidence="ECO:0000250|UniProtKB:Q2T9S0" FT VARIANT 2 FT /note="R -> K (in OZEMA2; loss of function in oocyte FT maturation; decreased alpha/beta-tubulin heterodimer FT assembly; dbSNP:rs869025273)" FT /evidence="ECO:0000269|PubMed:26789871" FT /id="VAR_076898" FT VARIANT 27..33 FT /note="Missing (in OZEMA2; loss of alpha/beta-tubulin FT heterodimer assembly; loss of function in meiotic spindle FT assembly)" FT /evidence="ECO:0000269|PubMed:27273344" FT /id="VAR_076899" FT VARIANT 54 FT /note="A -> V (in OZEMA2; loss of function in meiotic FT spindle assembly and oocyte maturation; when expressed in FT mouse oocytes it leads to abnormal spindle structure and FT maturation arrest; dbSNP:rs375210323)" FT /evidence="ECO:0000269|PubMed:32316999, FT ECO:0000269|PubMed:34509376" FT /id="VAR_087566" FT VARIANT 176 FT /note="S -> L (in OZEMA2; loss of function in oocyte FT maturation; loss of function in meiotic spindle assembly; FT decreased alpha/beta-tubulin heterodimer assembly; FT dbSNP:rs869025609)" FT /evidence="ECO:0000269|PubMed:26789871, FT ECO:0000269|PubMed:27273344" FT /id="VAR_076900" FT VARIANT 210 FT /note="I -> V (in OZEMA2; decreased alpha/beta-tubulin FT heterodimer assembly; loss of function in meiotic spindle FT assembly; dbSNP:rs781853492)" FT /evidence="ECO:0000269|PubMed:27273344" FT /id="VAR_076901" FT VARIANT 229 FT /note="V -> A (in OZEMA2; loss of function in oocyte FT maturation; decreased alpha/beta-tubulin heterodimer FT assembly; dbSNP:rs869025271)" FT /evidence="ECO:0000269|PubMed:26789871" FT /id="VAR_076902" FT VARIANT 238 FT /note="T -> M (in OZEMA2; decreased alpha/beta-tubulin FT heterodimer assembly; loss of function in meiotic spindle FT assembly; dbSNP:rs1057520306)" FT /evidence="ECO:0000269|PubMed:27273344" FT /id="VAR_076903" FT VARIANT 255 FT /note="V -> M (in OZEMA2; loss of function in meiotic FT spindle assembly; dbSNP:rs782269374)" FT /evidence="ECO:0000269|PubMed:27273344" FT /id="VAR_076904" FT VARIANT 262 FT /note="R -> Q (in OZEMA2; loss of function in oocyte FT maturation; decreased alpha/beta-tubulin heterodimer FT assembly; dbSNP:rs869025610)" FT /evidence="ECO:0000269|PubMed:26789871" FT /id="VAR_076905" FT VARIANT 262 FT /note="R -> W (in OZEMA2; decreased alpha/beta-tubulin FT heterodimer assembly; does not affect function in meiotic FT spindle assembly; dbSNP:rs782486119)" FT /evidence="ECO:0000269|PubMed:27273344" FT /id="VAR_076906" FT VARIANT 285 FT /note="T -> P (in OZEMA2; loss of function in meiotic FT spindle assembly)" FT /evidence="ECO:0000269|PubMed:27273344" FT /id="VAR_076907" FT VARIANT 300 FT /note="M -> I (in OZEMA2; loss of function in oocyte FT maturation; decreased alpha/beta-tubulin heterodimer FT assembly; dbSNP:rs869025612)" FT /evidence="ECO:0000269|PubMed:26789871" FT /id="VAR_076908" FT VARIANT 320 FT /note="R -> H (in OZEMA2; loss of function in meiotic FT spindle assembly and oocyte maturation; when expressed in FT mouse oocytes it leads to abnormal spindle structure and FT maturation arrest; dbSNP:rs1465781298)" FT /evidence="ECO:0000269|PubMed:34509376" FT /id="VAR_087567" FT VARIANT 345 FT /note="L -> F (in dbSNP:rs4880608)" FT /id="VAR_039240" FT VARIANT 348 FT /note="N -> S (in OZEMA2; loss of function in meiotic FT spindle assembly; dbSNP:rs1270068662)" FT /evidence="ECO:0000269|PubMed:27273344" FT /id="VAR_076909" FT VARIANT 363 FT /note="M -> T (in OZEMA2; loss of function in oocyte FT maturation; decreased alpha/beta-tubulin heterodimer FT assembly; dbSNP:rs869025611)" FT /evidence="ECO:0000269|PubMed:26789871" FT /id="VAR_076910" FT VARIANT 417 FT /note="D -> N (in OZEMA2; loss of function in oocyte FT maturation; loss of function in meiotic spindle assembly; FT decreased alpha/beta-tubulin heterodimer assembly; FT dbSNP:rs869025272)" FT /evidence="ECO:0000269|PubMed:26789871" FT /id="VAR_076911" SQ SEQUENCE 444 AA; 49776 MW; 3EC4AC10946BF590 CRC64; MREIVLTQIG QCGNQIGAKF WEVISDEHAI DSAGTYHGDS HLQLERINVY YNEASGGRYV PRAVLVDLEP GTMDSVRSGP FGQVFRPDNF IFGQCGAGNN WAKGHYTEGA ELMESVMDVV RKEAESCDCL QGFQLTHSLG GGTGSGMGTL LLSKIREEYP DRIINTFSIL PSPKVSDTVV EPYNATLSVH QLIENADETF CIDNEALYDI CSKTLKLPTP TYGDLNHLVS ATMSGVTTCL RFPGQLNADL RKLAVNMVPF PRLHFFMPGF APLTSRGSQQ YRALTVAELT QQMFDAKNMM AACDPRHGRY LTAAAIFRGR MPMREVDEQM FNIQDKNSSY FADWLPNNVK TAVCDIPPRG LKMSATFIGN NTAIQELFKR VSEQFTAMFR RKAFLHWYTG EGMDEMEFTE AESNMNDLVS EYQQYQDATA EEEEDEEYAE EEVA //